Compliance Rate
Compliance Rate
66.0%
Compliant submissions
66
Incompliant submissions
34
Total trials
100
Your Clinical Trials
Showing 25 of 100 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/07/22
End: 01/09/22
Due: 01/10/22
Phase: N/A
Priority: Normal
Start: 01/17/22
End: 01/19/22
Due: 01/20/22
Phase: N/A
Priority: Normal
Start: 01/27/22
End: 01/29/22
Due: 01/30/22
Phase: N/A
Priority: Normal
Start: 02/06/22
End: 02/08/22
Due: 02/09/22
Phase: N/A
Priority: Normal
Start: 02/16/22
End: 02/18/22
Due: 02/19/22
Phase: N/A
Priority: Normal
Start: 02/26/22
End: 02/28/22
Due: 03/01/22
Phase: N/A
Priority: Normal
Start: 03/08/22
End: 03/10/22
Due: 03/11/22
Phase: N/A
Priority: Normal
Start: 03/18/22
End: 03/20/22
Due: 03/21/22
Phase: N/A
Priority: Normal
Start: 03/28/22
End: 03/30/22
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 04/07/22
End: 04/09/22
Due: 04/10/22
Phase: N/A
Priority: Normal
Start: 06/16/22
End: 06/18/22
Due: 06/19/22
Phase: N/A
Priority: Normal
Start: 07/06/22
End: 07/08/22
Due: 07/09/22
Phase: N/A
Priority: Normal
Start: 01/02/23
End: 01/04/23
Due: 01/05/23
Phase: N/A
Priority: Normal
Start: 09/30/93
End: 07/31/02
Due: 07/31/03
Phase: N/A
Priority: Normal
Start: 07/31/86
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 09/30/04
Due: 09/30/05
Phase: N/A
Priority: Normal
Start: 06/30/87
End: 08/31/98
Due: 08/31/99
Phase: N/A
Priority: Normal
Start: -
End: 06/30/02
Due: 06/30/03
Phase: N/A
Priority: Normal
Start: 04/30/98
End: 03/31/03
Due: 03/31/04
Phase: N/A
Priority: Normal
Start: 06/30/95
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/94
End: 03/31/96
Due: 03/31/97
Phase: N/A
Priority: Normal
Start: 09/30/98
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: -
End: 08/31/01
Due: 08/31/02
Phase: N/A
Priority: Normal
Start: 04/30/96
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 02/28/90
Due: 02/28/91
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study 6 | NCT00000005 | Organization 6 | user6@example.com | Compliant | 2022-01-07 | 2022-01-09 | 2022-01-10 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 16 | NCT00000015 | Organization 16 | user6@example.com | Incompliant | 2022-01-17 | 2022-01-19 | 2022-01-20 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 26 | NCT00000025 | Organization 26 | user6@example.com | Compliant | 2022-01-27 | 2022-01-29 | 2022-01-30 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 36 | NCT00000035 | Organization 36 | user6@example.com | Compliant | 2022-02-06 | 2022-02-08 | 2022-02-09 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 46 | NCT00000045 | Organization 46 | user6@example.com | Compliant | 2022-02-16 | 2022-02-18 | 2022-02-19 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 56 | NCT00000055 | Organization 56 | user6@example.com | Compliant | 2022-02-26 | 2022-02-28 | 2022-03-01 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 66 | NCT00000065 | Organization 66 | user6@example.com | Compliant | 2022-03-08 | 2022-03-10 | 2022-03-11 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 76 | NCT00000075 | Organization 76 | user6@example.com | Compliant | 2022-03-18 | 2022-03-20 | 2022-03-21 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 86 | NCT00000085 | Organization 86 | user6@example.com | Incompliant | 2022-03-28 | 2022-03-30 | 2022-03-31 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 96 | NCT00000095 | Organization 96 | user6@example.com | Incompliant | 2022-04-07 | 2022-04-09 | 2022-04-10 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 166 | NCT00000165 | Organization 66 | user6@example.com | Incompliant | 2022-06-16 | 2022-06-18 | 2022-06-19 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 186 | NCT00000185 | Organization 86 | user6@example.com | Compliant | 2022-07-06 | 2022-07-08 | 2022-07-09 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 366 | NCT00000365 | Organization 66 | user6@example.com | Incompliant | 2023-01-02 | 2023-01-04 | 2023-01-05 | 2025-07-01 | Clinician | 2025-07-01 |
| PATHWAYS--FULL SCALE STUDY | NCT00000545 | National Heart, Lung, and Blood Institute (NHLBI) | user6@example.com | Incompliant | 1993-09-30 | 2002-07-31 | 2003-07-31 | 2025-07-01 | - | 2025-07-14 |
| Diuretics, Hypertension, and Arrhythmias Clinical Trial | NCT00000525 | University of California, San Francisco | user6@example.com | Compliant | 1986-07-31 | - | - | 2025-07-01 | - | 2025-07-14 |
| dnaJ Peptide for Relieving Rheumatoid Arthritis | NCT00000435 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | user6@example.com | Incompliant | 1999-09-30 | 2004-09-30 | 2005-09-30 | 2025-07-01 | - | 2025-07-14 |
| Emory Angioplasty Versus Surgery Trial (EAST) | NCT00000465 | National Heart, Lung, and Blood Institute (NHLBI) | user6@example.com | Compliant | 1987-06-30 | 1998-08-31 | 1999-08-31 | 2025-07-01 | - | 2025-07-14 |
| Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo) | NCT00000765 | National Institute of Allergy and Infectious Diseases (NIAID) | user6@example.com | Compliant | - | 2002-06-30 | 2003-06-30 | 2025-07-01 | - | 2025-07-14 |
| Physical Activity, Calcium, and Bone in Children | NCT00000415 | South Dakota State University | user6@example.com | Compliant | 1998-04-30 | 2003-03-31 | 2004-03-31 | 2025-07-01 | - | 2025-07-14 |
| The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study | NCT00000155 | National Eye Institute (NEI) | user6@example.com | Incompliant | 1995-06-30 | - | - | 2025-07-01 | - | 2025-07-14 |
| Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 | NCT00000355 | National Institute on Drug Abuse (NIDA) | user6@example.com | Incompliant | 1994-11-30 | 1996-03-31 | 1997-03-31 | 2025-07-01 | - | 2025-07-14 |
| Effects of Jumping on Growing Bones | NCT00000405 | Oregon State University | user6@example.com | Compliant | 1998-09-30 | 2008-11-30 | 2009-11-30 | 2025-07-01 | - | 2025-07-14 |
| A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection | NCT00000895 | National Institute of Allergy and Infectious Diseases (NIAID) | user6@example.com | Compliant | - | 2001-08-31 | 2002-08-31 | 2025-07-01 | - | 2025-07-14 |
| Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 | NCT00000345 | National Institute on Drug Abuse (NIDA) | user6@example.com | Incompliant | 1996-04-30 | - | - | 2025-07-01 | - | 2025-07-14 |
| A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection | NCT00000995 | National Institute of Allergy and Infectious Diseases (NIAID) | user6@example.com | Compliant | - | 1990-02-28 | 1991-02-28 | 2025-07-01 | - | 2025-07-14 |